322 related articles for article (PubMed ID: 8799170)
1. Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region.
Jin F; Wienecke R; Xiao GH; Maize JC; DeClue JE; Yeung RS
Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9154-9. PubMed ID: 8799170
[TBL] [Abstract][Full Text] [Related]
2. Presence of potent transcriptional activation domains in the predisposing tuberous sclerosis (Tsc2) gene product of the Eker rat model.
Tsuchiya H; Orimoto K; Kobayashi K; Hino O
Cancer Res; 1996 Feb; 56(3):429-33. PubMed ID: 8564946
[TBL] [Abstract][Full Text] [Related]
3. Identification of the coding sequences responsible for Tsc2-mediated tumor suppression using a transgenic rat system.
Momose S; Kobayashi T; Mitani H; Hirabayashi M; Ito K; Ueda M; Nabeshima Y; Hino O
Hum Mol Genet; 2002 Nov; 11(24):2997-3006. PubMed ID: 12417521
[TBL] [Abstract][Full Text] [Related]
4. The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis.
Xiao GH; Shoarinejad F; Jin F; Golemis EA; Yeung RS
J Biol Chem; 1997 Mar; 272(10):6097-100. PubMed ID: 9045618
[TBL] [Abstract][Full Text] [Related]
5. The GAP-related domain of tuberin, the product of the TSC2 gene, is a target for missense mutations in tuberous sclerosis.
Maheshwar MM; Cheadle JP; Jones AC; Myring J; Fryer AE; Harris PC; Sampson JR
Hum Mol Genet; 1997 Oct; 6(11):1991-6. PubMed ID: 9302281
[TBL] [Abstract][Full Text] [Related]
6. Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis.
Kerfoot C; Wienecke R; Menchine M; Emelin J; Maize JC; Welsh CT; Norman MG; DeClue JE; Vinters HV
Brain Pathol; 1996 Oct; 6(4):367-75. PubMed ID: 8944308
[TBL] [Abstract][Full Text] [Related]
7. Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene.
Yeung RS; Xiao GH; Jin F; Lee WC; Testa JR; Knudson AG
Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11413-6. PubMed ID: 7972075
[TBL] [Abstract][Full Text] [Related]
8. Suppression of the neoplastic phenotype by replacement of the Tsc2 gene in Eker rat renal carcinoma cells.
Orimoto K; Tsuchiya H; Kobayashi T; Matsuda T; Hino O
Biochem Biophys Res Commun; 1996 Feb; 219(1):70-5. PubMed ID: 8619830
[TBL] [Abstract][Full Text] [Related]
9. Tuberin phosphorylation regulates its interaction with hamartin. Two proteins involved in tuberous sclerosis.
Aicher LD; Campbell JS; Yeung RS
J Biol Chem; 2001 Jun; 276(24):21017-21. PubMed ID: 11290735
[TBL] [Abstract][Full Text] [Related]
10. Pathological mutations in TSC1 and TSC2 disrupt the interaction between hamartin and tuberin.
Hodges AK; Li S; Maynard J; Parry L; Braverman R; Cheadle JP; DeClue JE; Sampson JR
Hum Mol Genet; 2001 Dec; 10(25):2899-905. PubMed ID: 11741833
[TBL] [Abstract][Full Text] [Related]
11. Role of the tuberous sclerosis gene-2 product in cell cycle control. Loss of the tuberous sclerosis gene-2 induces quiescent cells to enter S phase.
Soucek T; Pusch O; Wienecke R; DeClue JE; Hengstschläger M
J Biol Chem; 1997 Nov; 272(46):29301-8. PubMed ID: 9361010
[TBL] [Abstract][Full Text] [Related]
12. Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity.
Wienecke R; König A; DeClue JE
J Biol Chem; 1995 Jul; 270(27):16409-14. PubMed ID: 7608212
[TBL] [Abstract][Full Text] [Related]
13. Loss of tuberin, the tuberous-sclerosis-complex-2 gene product is associated with angiogenesis.
Nguyen-Vu PA; Fackler I; Rust A; DeClue JE; Sander CA; Volkenandt M; Flaig M; Yeung RS; Wienecke R
J Cutan Pathol; 2001 Oct; 28(9):470-5. PubMed ID: 11553313
[TBL] [Abstract][Full Text] [Related]
14. Renal carcinogenesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ-line Tsc2 mutation in mice.
Kobayashi T; Minowa O; Kuno J; Mitani H; Hino O; Noda T
Cancer Res; 1999 Mar; 59(6):1206-11. PubMed ID: 10096549
[TBL] [Abstract][Full Text] [Related]
15. Absence of allelic loss in cytomegalic neurons of cortical tuber in the Eker rat model of tuberous sclerosis.
Mizuguchi M; Mori M; Nozaki Y; Momoi MY; Itoh M; Takashima S; Hino O
Acta Neuropathol; 2004 Jan; 107(1):47-52. PubMed ID: 14566415
[TBL] [Abstract][Full Text] [Related]
16. Evidence for separable functions of tuberous sclerosis gene products in mammalian cell cycle regulation.
Miloloza A; Kubista M; Rosner M; Hengstschläger M
J Neuropathol Exp Neurol; 2002 Feb; 61(2):154-63. PubMed ID: 11853018
[TBL] [Abstract][Full Text] [Related]
17. The tuberin-hamartin complex negatively regulates beta-catenin signaling activity.
Mak BC; Takemaru K; Kenerson HL; Moon RT; Yeung RS
J Biol Chem; 2003 Feb; 278(8):5947-51. PubMed ID: 12511557
[TBL] [Abstract][Full Text] [Related]
18. Tuberous sclerosis complex and DNA repair.
Habib SL
Adv Exp Med Biol; 2010; 685():84-94. PubMed ID: 20687497
[TBL] [Abstract][Full Text] [Related]
19. TSC2 missense mutations inhibit tuberin phosphorylation and prevent formation of the tuberin-hamartin complex.
Nellist M; Verhaaf B; Goedbloed MA; Reuser AJ; van den Ouweland AM; Halley DJ
Hum Mol Genet; 2001 Dec; 10(25):2889-98. PubMed ID: 11741832
[TBL] [Abstract][Full Text] [Related]
20. Germ-line mutational analysis of the TSC2 gene in 90 tuberous-sclerosis patients.
Au KS; Rodriguez JA; Finch JL; Volcik KA; Roach ES; Delgado MR; Rodriguez E; Northrup H
Am J Hum Genet; 1998 Feb; 62(2):286-94. PubMed ID: 9463313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
